Revisiting late loss and neointimal volumetric measurements in a drug‐eluting stent trial: Analysis from the SPIRIT FIRST trial
- 8 January 2006
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 67 (2), 188-197
- https://doi.org/10.1002/ccd.20581
Abstract
This study was conducted to reevaluate the significance of angiographic late loss and to assess the agreement between new proposed neointimal volumetric measurements derived from quantitative coronary angiography (QCA) and standard intravascular ultrasound (IVUS)–based parameters. Neointimal volumetric measurements may better estimate the magnitude of neointimal growth after stenting than late loss. In 56 in‐stent segments (27, everolimus; 29, bare metal) in the SPIRIT FIRST study, we compared QCA measures with the corresponding IVUS parameters. Two IVUS‐late loss models were derived from minimal luminal diameter (MLD) using either a circular model or a so‐called projected MLD. QCA‐neointimal volume was calculated as follows: stent volume (mean area of the stented segment × stent length) at post procedure − lumen volume (mean area of the stented segment × stent length) at follow‐up (the stent length either from nominal stent length or the length measured by QCA). Videodensitometric neointimal volume was also evaluated. Each of the three neointimal volume and percentage volume obstruction by QCA showed significant correlation with the corresponding IVUS parameters (r = 0.557–0.594, P < 0.0001), albeit with a broad range of limits of agreement. Late loss and volumetric measurements by QCA had a broader range of standard deviation than those by IVUS. QCA‐volumetric measurements successfully confirmed the efficacy of everolimus‐eluting stents over bare metal stents (P < 0.05). Our proposed QCA volumetric measurements may be a practical surrogate for IVUS measurements and a discriminant methodological approach for assessment of treatment effects of drug‐eluting stents.Keywords
This publication has 18 references indexed in Scilit:
- Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: Analysis from the TAXUS-IV trialJournal of the American College of Cardiology, 2005
- Relationship of Late Loss in Lumen Diameter to Coronary Restenosis in Sirolimus-Eluting StentsCirculation, 2005
- Comparison of quantitative angiographic parameters with the magnitude of neointimal hyperplasia measured by volumetric intravascular ultrasound in patients treated with bare metal and nonpolymeric paclitaxel-coated stentsThe American Journal of Cardiology, 2005
- Actinomycin-eluting stent for coronary revascularizationA randomized feasibility and safety study: The ACTION trialJournal of the American College of Cardiology, 2004
- Methodological and clinical implications of the relocation of the minimal luminal diameter after intracoronary radiation therapyJournal of the American College of Cardiology, 2000
- Videodensitometric quantitative angiography after coronary balloon angioplasty, compared to edge-detection quantitative angiography and intracoronary ultrasound imagingEuropean Heart Journal, 2000
- Benefit of intracoronary ultrasound in the deployment of Palmaz-Schatz stentsJournal of the American College of Cardiology, 1994
- Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near gaussian distribution: A quantitative angiographic study in 1,445 successfully dilated lesionsJournal of the American College of Cardiology, 1992
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- Assessment of percutaneous transluminal coronary angioplasty by quantitative coronary angiography: Diameter versus densitometric area measurementsThe American Journal of Cardiology, 1984